UW spin-off’s first venture round enables clinical trials for 2 DNA vaccines for prostate cancer
A University of Wisconsin professor’s cancer vaccine spin-off has locked in its first venture round to carry two potential prostate cancer treatments through early-stage clinical trials. Madison Vaccines Inc. began raising its $8 million round at the end of 2013, according to a SEC filing, and closed it in January with participation from Wisconsin-based investors […]